CausalSentinel

Protein Dossier — PIANP (PILR alpha-associated neural protein)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Neuroticism 0.0265 0.0177 0.134 Wald ratio 1 cis NA
Coronary heart disease -0.113 0.0787 0.153 Wald ratio 1 cis NA
Amyotrophic lateral sclerosis 0.126 0.0981 0.201 Wald ratio 1 cis NA
Depressive symptoms 0.0221 0.0177 0.211 Wald ratio 1 cis NA

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

6 association rows across 4 traits (6 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
PILR alpha-associated neural protein levels 1e-22 rs11064321 2 GCST90249001 no MR -> candidate analysis
CD4 protein levels 1e-21 rs2091780 1 GCST90468636 no MR -> candidate analysis
PILR alpha-associated neural protein levels (PIANP.9599.6.3) 5e-17 rs11064321 2 GCST90242266 no MR -> candidate analysis
Bone mineral density mean 4e-9 rs73049715 1 GCST90321120 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

No genetically-associated diseases retrieved from Open Targets.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=0.031, LOEUF=0.758 — LoF-tolerant
GWAS Catalog 74 unique SNPs / 148 rows
ClinVar 99 records; 5 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance